NOVEL ANTI-HLA-A2 ANTIBODIES AND USES THEREOF

Inventors
Documents
Applicants
  • Sangamo Therapeutics France
  • TXCELL
  • University of British Columbia
Contact Info
Brett Sharp
Associate Director Technology Transfer
(604) 822-8588
[email protected]

Abstract

The present invention relates to a novel anti-HLA-A2 antibody, and to a chimeric antigen receptor comprising said HLA-A2 antibody. The present invention further relates to an immune cell expressing said chimeric receptor antigen, and to therapeutic uses thereof, in particular for treating or preventing graft rejection or GVHD.